# Study Evaluating Sphenopalatine Ganglion Block (SPGB) for Treatment of Postdural Puncture Headache (PDPH)

> **NCT02365909** · EARLY_PHASE1 · TERMINATED · sponsor: **University of Arkansas** · enrollment: 6 (actual)

## Conditions studied

- Postdural Puncture Headache

## Interventions

- **DRUG:** 0.5% bupivacaine
- **DRUG:** normal saline

## Key facts

- **NCT ID:** NCT02365909
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-06-29
- **Primary completion:** 2016-08-30
- **Final completion:** 2016-08-30
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Study stopped due to difficulty recruiting patients
- **Last updated:** 2017-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02365909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02365909, "Study Evaluating Sphenopalatine Ganglion Block (SPGB) for Treatment of Postdural Puncture Headache (PDPH)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02365909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*